To investigate the role of SNRPA overexpression in transcriptomic and splicing changes in hepatocellular carcinoma (HCC) cells, highlighting its potential as a therapeutic target.
Key Findings:
SNRPA overexpression resulted in 498 differentially expressed genes (DEGs) and 2316 alternative splicing events (RASEs), with implications for HCC progression.
Twelve RNA-binding proteins (RBPs) involved in HCC were modulated by SNRPA overexpression.
Functional annotation revealed enrichment in pathways related to RNA processing, transcription, and cell division.
Interpretation:
SNRPA may play dual roles in RNA binding and splicing modulation, influencing pathways linked to tumorigenesis and cellular proliferation in HCC, suggesting a potential target for therapeutic intervention.
Limitations:
Further functional confirmation, including in vivo studies, is required to establish direct causal implications of SNRPA in HCC.
The study primarily focuses on in vitro models, which may not fully replicate in vivo conditions.
Conclusion:
SNRPA overexpression correlates with significant transcriptomic and splicing changes in HCC, suggesting its potential role in cancer progression and as a target for future therapies.
